Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100:S1–S276.
2. Yeo SC, Goh SM, Barratt J. Is immunoglobulin A nephropathy different in different ethnic populations? Nephrology. 2019;24(9):885–95.
3. Zhang H, Barratt J. Is IgA nephropathy the same disease in different parts of the world? Semin Immunopathol. 2021;43(5):707–15.
4. Rodrigues JC, Haas M, Reich HN. IgA nephropathy. Clin J Am Soc Nephrol. 2017;12(4):677–86.
5. Kwon CS, Daniele P, Forsythe A, Ngai C. A systematic literature review of the epidemiology, health-related quality of life impact, and economic burden of immunoglobulin a nephropathy. J Health Econ Outcomes Res. 2021;8(2):36–45.